66 avsnitt
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies
2026-10-17 | 24 min.Featuring a slide presentation from Dr Julia Rotow, including the following topics:
Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00)
Key findings from the Phase III HARMONi-6 study; ongoing Phase III HARMONi-3 study (5:12)
Key findings from the Phase III HARMONi-2 study; ongoing Phase III HARMONi-7 study (9:59)
Clinician insights about the potential role of ivonescimab in the front-line setting (12:02)
Impetus for investigating ivonescimab in the relapsed/refractory (R/R) EGFR-mutant setting (14:01)
Key findings from the Phase III HARMONi-A and HARMONi studies (16:07)
Clinician insights about the potential role of ivonescimab in the treatment of R/R EGFR-mutant NSCLC; other novel PD-1/PD-L1 x VEGF bispecific antibodies under investigation (20:30)
CME information and select publicationsLung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
2026-10-04 | 50 min.Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
EGFR Mutations (2:23)
HER2 Alterations (22:40)
Available and Investigational Immunotherapies (32:14)
Small Cell Lung Cancer (40:48)
CME information and select publicationsFor Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon
2026-09-30 | 58 min.Featuring an interview with Dr Alexander E Drilon, including the following topics:
Overview of targetable biomarkers in lung cancer (0:00)
Biomarker testing for genomic alterations in lung cancer (5:24)
Overview of ROS1 alterations in lung cancer (13:44)
Efficacy data with ROS1 inhibitors for lung cancer (17:02)
Safety data with ROS1 inhibitors for lung cancer (21:15)
Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1 fusion (28:56)
Case: A man in his late teens diagnosed with de novo advanced NSCLC with a ROS1 alteration achieves a dramatic response to therapy (46:16)
Case: A woman in her early 60s with a history of ROS1-altered NSCLC receives several ROS1 inhibitors (50:52)
NCPD information and select publications- Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:
Introduction (0:00)
Best Option for Your Patient (1:28)
Biological Considerations (6:26)
KRAS G12C Inhibitors (11:33)
Second-Line Treatment (13:02)
Current Clinical Trials in the First-Line Metastatic Setting (32:18)
Current Clinical Trials in the Localized Setting (49:52)
Current Clinical Trials with New Treatment Combinations and Agents (53:51)
CME information and select publications Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
2026-09-01 | 54 min.Featuring an interview with Prof Ticiana Leal, including the following topics:
Pathophysiology and clinical signs and symptoms (0:00)
Screening and/or diagnostic approaches (5:45)
Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
Key clinical trial data for amifampridine and practicalities of its administration (14:05)
Building awareness among patients, caregivers and the oncology community (22:37)
Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
Current research and potential developments in the treatment of SCLC (48:32)
CME information and select publications
Fler podcasts i Hälsa och motion
Trendiga poddar i Hälsa och motion
Om Lung Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Podcast-webbplatsLyssna på Lung Cancer Update, Bara En Till... - Om beroende & medberoende och många andra poddar från världens alla hörn med radio.se-appen

Hämta den kostnadsfria radio.se-appen
- Bokmärk stationer och podcasts
- Strömma via Wi-Fi eller Bluetooth
- Stödjer Carplay & Android Auto
- Många andra appfunktioner
Lung Cancer Update: Poddsändningar i Familj




































